Login
← Go Back
Supriya Lifescience
SUPRIYA · Pharma > Pharmaceuticals & Drugs · Chairman: Satish Waman Wagh · MD: Satish Waman Wagh · Listing date: Dec. 29, 2021
Stock Price vs Company Growth
1d
3.5%
1w
11.3%
1m
14.5%
3m
21.8%
6m
5.2%
1y
10.5%
all
12.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 807 3.5%
546
817
Company Overview
Sales
828 Cr
Growth: 12.1%
Profit after Tax
209 Cr
Growth: 12.9%
Small Cap
6,497 Cr
P/E: 31.1x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 828
Growth 12.1%
EBITDA 35.5%
P/S 7.8x
Dividend 0.2%
P/E 31.1x
Book Value ₹ 2
PEG Ratio 2.6x
ROE 999.0%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.
Belongs to (12 Indices) view more
Investors (5)
jyotsana
rajeev4
shivani....
Followers (1)
varsha96